Product/Composition:- | Dobutamine |
---|---|
Strength:- | 12.5 mg/mL |
Form:- | Intravenous (IV) Injection |
Reference Brands:- | Dobutrex(US), Dobutamina Hameln, Dobutamine Accord, Dobutamine Fresenius Kabi(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Dobutamine is an essential IV inotrope used in ICU and cardiac care for heart failure and shock. Available in 12.5 mg/mL strength, common brands include Dobutamina Hameln and Dobutamine Fresenius. It is widely supplied to hospitals and healthcare institutions through pharma B2B and critical care procurement channels.
Dobutamine is a fast-acting inotropic agent used to treat acute heart failure and cardiogenic shock by enhancing cardiac output. Administered via intravenous infusion, it acts on beta-1 adrenergic receptors to improve myocardial contractility. Dobutamine is commonly available in 12.5 mg/mL concentration, supplied in 250 mg/20 mL and 500 mg/40 mL vials or ready-to-use infusion bags. Brands like Dobutamina Hameln and Dobutamine Fresenius are well-recognized in the EU, with various generics available in the US. Dobutamine is a critical care medication procured by hospitals, ICUs, and emergency departments, often listed in institutional tenders and group purchasing organizations.